ChiCTR1800018533
尚未开始
/
/
/
2018-09-05
/
/
Middle-ear disorder
建立寬頻聲阻抗於中國人耳朵的標準數據
建立寬頻聲阻抗於中國人耳朵的標準數據
To establish Chinese normative data of wideband Energy Absorbance, which, is an emerging objective audiological measurement for revealing aural acoustic transfer function over a board frequency range.
横断面
Ⅰ期
N/A
N/A
Dept. of Otorhinolaryngology, Head and Neck Surgery, CUHK
/
360
/
1990-01-01
1990-01-01
/
For normative data, we plan to recruit thirty participants in 1:1 gender ratio in each of the following age groups: 3 – 5;11 years, 6 – 9;11 years, 10 – 30 years, 31 – 45 years, 46 – 60 years, 61 – 75 years, 76 years old and above; corresponding to a minimum of 210 participants. The inclusion criteria are: 1. Outpatients of the Dept. of Ear, Nose and Throat of the Prince of Wales Hospital (PWH, NTEC) who are aged 3 years and above and referred to the PWH Audiology Centre for audiological assessments; 2. Negative history of chronic middle-ear disease; 3. 226 Hz tympanometric criteria within normal limits, defined as having middle-ear compliance ≥ 0.3 ml, middle-ear pressure within +/- 100 daPa, and equivalent ear-canal volume ≤ 2.0 cm3; 4. Absence of significant air-bone gaps in the ear to be assessed, defined as having air-bone gap of no greater than 10 dB at 0.5, 1, 2, & 4 kHz; 5. No gross eardrum abnormalities or excessive cerumen as revealed via otoscopic examination, in the ear to be assessed; 6. Able to understand the consenting procedure and willing to provide written consent; for children aged under 18 years written consent will be obtained from accompanying parent or guardian. For disease-specific data, we plan to recruit 150 adult patients meeting the following criteria: 1. Outpatients of the PWH Dept. of Ear, Nose and Throat who are aged 18 years and above and referred to the PWH Audiology Centre for audiological assessments; 2. Referral reason is middle-ear related, e.g. conductive hearing loss, otosclerosis, otitis media effusion (OME), tympanic membrane perforation, middle-ear disease; 3. Referred for standard tympanometry as well; 4. Absence of any of the exclusion criteria abovementioned for normative sample.;
请登录查看Adult or child who presents any of the followings will be excluded: active discharge in ear canal, swollen ear canal, atresia, failure to comply with test procedures including insertion of test probe.;
请登录查看香港中文大學頭頸外科耳鼻咽喉科
/
香港中文大學頭頸外科耳鼻咽喉科的其他临床试验
Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验(FIH)成功开展,国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药:超长效靶向TSLP抗体哮喘二期临床取得阳性结果,三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-09-10
-
2026-09-09
-
2026-09-08
-
摩熵咨询 20 5
-
摩熵咨询 20 8
-
摩熵咨询 34 43
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-09-10
-
2026-09-10
-
2026-09-10
-
摩熵咨询 35 60
-
摩熵咨询 28 52
-
摩熵咨询 34 37
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29

